Back to Authors

Jeraldo, Patricio

https://orcid.org/0000-0003-0282-4217

Mayo Clinic

Mayo Clinic

Citations 31

Metronidazole- and Carbapenem-Resistant Bacteroides thetaiotaomicron Isolated in Rochester, Minnesota, in 2014
Sadarangani, Sapna P. , Cunningham, Scott A. , Jeraldo, Patricio , Wilson, John , Khare, Reeti , Patel, Robin , Jeraldo, Patricio R , Sadarangani, Sapna , Patel, Robin , Cunningham, Scott A

Antimicrobial Agents and Chemotherapy | May 5, 2015 | Volume: 59 | Issue: 7 | Pages: 4157-4161

10.1128/aac.00677-15 Get It

ABSTRACT Emerging antimicrobial resistance in members of the Bacteroides fragilis group is a concern in clinical medicine. Although metronidazole and carbapenem resistance have been reported in Bacteroides thetaiotaomicron , a member of the B. fragilis group, they have not, to the best of our knowledge, been reported together in the same B. thetaiotaomicron isolate. Herein, we report isolation of piperacillin-tazobactam-, metronidazole-, clindamycin-, ertapenem-, and meropenem-resistant B. thetaiotaomicron from a patient with postoperative intra-abdominal abscess and empyema. Whole-genome sequencing demonstrated the presence of nimD with at least a portion of IS 1169 upstream, a second putative nim gene, two β-lactamase genes (one of which has not been previously reported), two tetX genes, tetQ , ermF , two cat genes, and a number of efflux pumps. This report highlights emerging antimicrobial resistance in B. thetaiotaomicron and the importance of identification and antimicrobial susceptibility testing of selected anaerobic bacteria.